Comment about the safety of intravenous voriconazole formulated with sulfobutylether beta-cyclodextrin

Expert Opin Drug Saf. 2022 Jan;21(1):133-134. doi: 10.1080/14740338.2021.1978976. Epub 2021 Sep 20.

Authors

Linlin Wang^{1

2}, Zanling Zhang^{1

2}

Affiliations

¹ Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, Hunan, China.
² Institute for Rational and Safe Medication Practices, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.

PMID: 34494496
DOI: 10.1080/14740338.2021.1978976

No abstract available

Publication types

Comment

MeSH terms

Humans
Voriconazole / adverse effects
beta-Cyclodextrins* / adverse effects

Substances

beta-Cyclodextrins
Voriconazole